Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.
Definitive Healthcare Corp. (NASDAQ: DH) is a data and analytics company focused on healthcare commercial intelligence, and its news flow reflects this role in the U.S. healthcare market. The company regularly issues press releases detailing quarterly financial results, business performance and guidance, giving investors and analysts insight into trends in its subscription-based platform and related metrics.
News about Definitive Healthcare often includes earnings announcements for its fiscal quarters, where it discusses revenue, net loss or income, non-GAAP measures such as Adjusted EBITDA and Adjusted Net Income, and cash flow metrics. These releases also highlight customer wins across end markets like medical device companies, digital health organizations, healthcare revenue cycle management firms, regional health systems, healthcare-focused private equity firms and healthcare advertising agencies.
Another important category of news involves corporate developments and leadership updates. The company reports inducement equity awards to senior leaders, changes in executive roles, and board-level updates, such as director resignations and committee appointments. These items provide context on how Definitive Healthcare structures its leadership and aligns compensation with its growth plans.
Definitive Healthcare also announces its participation in investor conferences and the timing of its quarterly financial results conference calls and webcasts. These updates indicate when management will discuss financial performance and outlook with the investment community.
By following the DH news feed, readers can monitor the company’s financial disclosures, leadership and governance changes, customer and market highlights, and investor relations events in one place. This page can be a useful reference for tracking how Definitive Healthcare communicates its progress and priorities over time.
Definitive Healthcare has integrated extensive Asian data sources into Monocl ExpertInsight, enhancing its platform with over 11 million worldwide expert profiles, focusing on the Chinese and Japanese healthcare markets. This expansion responds to customer demand for deeper insights in the APAC region, facilitating better expert identification and engagement strategies. The update includes local language capabilities, aiding medical professionals in understanding local experiences and exploring new scientific activities. This move aims to strengthen relationships and expand market presence in Asia-Pacific.
Definitive Healthcare Corp. (Nasdaq: DH) will release its third quarter financial results on November 8, 2021, after market close. A conference call is scheduled for 5:00 PM ET to discuss the results. Investors can access a live audio webcast on Definitive Healthcare’s Investor Relations website and dial in via provided numbers. The call will also be available for replay until November 22, 2021. Definitive Healthcare focuses on providing data and analytics to enhance commercial success in the healthcare sector.
Definitive Healthcare (Nasdaq: DH) has launched Latitude Reporting, a product that enables real-time custom patient cohort analysis targeting specific disease states. The tool allows life sciences companies to swiftly analyze extensive medical and prescription claims data, enhancing their go-to-market strategies. Users can create and adjust patient cohorts, gaining insights from billions of claims to support informed commercial decisions. Latitude Reporting aims to streamline healthcare data utilization, catering to various roles within the industry.
Definitive Healthcare (Nasdaq: DH) has appointed Robert Musslewhite as President, enhancing its Executive Leadership Team during a period of rapid growth. Musslewhite brings extensive healthcare experience, previously leading OptumInsight and serving on Definitive Healthcare's board. With a total addressable market exceeding $10 billion and a unique SaaS platform, the company is set for significant impact in the healthcare industry. His expertise is expected to drive the development of new commercial intelligence solutions.
Definitive Healthcare Corp. has successfully closed its initial public offering, selling 17,888,888 shares of Class A common stock at $27.00 per share. This offering includes the full exercise of the underwriters' option for an additional 2,333,333 shares, yielding approximately $483 million in gross proceeds. The stock began trading on the Nasdaq Global Select Market under the symbol DH on September 15, 2021. Major underwriters include Goldman Sachs and J.P. Morgan.
Definitive Healthcare Corp. has announced the pricing of its initial public offering (IPO) for 15,555,555 shares of Class A common stock at $27.00 per share. The offering allows underwriters a 30-day option to buy an additional 2,333,333 shares. Trading on the Nasdaq Global Select Market under ticker symbol 'DH' is set to start on September 15, 2021, with closure of the offering anticipated on September 17, 2021. Goldman Sachs and J.P. Morgan are leading the underwriting team.